Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer.
about
Low-dose valproic acid with low-dose gemcitabine augments MHC class I-related chain A/B expression without inducing the release of soluble MHC class I-related chain A/B.A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity.
P2860
Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Low-dose gemcitabine induces m ...... response in pancreatic cancer.
@en
type
label
Low-dose gemcitabine induces m ...... response in pancreatic cancer.
@en
prefLabel
Low-dose gemcitabine induces m ...... response in pancreatic cancer.
@en
P2093
P2860
P1476
Low-dose gemcitabine induces m ...... response in pancreatic cancer.
@en
P2093
Ali K Ahmed
Hidehiro Tajima
Hirohisa Kitagawa
Hiroyuki Takamura
Hisatoshi Nakagawara
Isamu Makino
John W Harmon
Kenji Miki
Mark D Duncan
Sachio Fushida
P2860
P2888
P356
10.1007/S10238-015-0394-X
P577
2015-10-08T00:00:00Z
P6179
1040000215